Does Intravenous Administration of Recombinant Tissue Plasminogen Activator for Ischemic Stroke can Cause Inferior Myocardial Infarction?

Recombinant tissue plasminogen activator (rTPA) is one of the main portions of acute ischemic stroke management, but unfortunately has some complications. Myocardial infarction (MI) is a hazardous complication of administration of intravenous rTPA that has been reported recently. A 78-year-old lady...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neurol Int
Autors principals: Almasi, Mostafa, Razmeh, Saeed, Habibi, Amir Hassan, Rezaee, Amir Hassan
Format: Artigo
Idioma:Inglês
Publicat: PAGEPress Publications, Pavia, Italy 2016
Matèries:
Case Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4935817/
https://ncbi.nlm.nih.gov/pubmed/27441068
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4081/ni.2016.6617
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars